Celldex Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $25.9M | $424.0M | $25.3M |
| Jun 2022 | $37.9M | $403.0M | $28.4M |
| Sep 2022 | $23.8M | $369.2M | $18.6M |
| Dec 2022 | $26.5M | $352.7M | $29.4M |
| Mar 2023 | $21.8M | $324.5M | $54.1M |
| Jun 2023 | $21.8M | $299.3M | $28.2M |
| Sep 2023 | $33.5M | $280.3M | $21.1M |
| Dec 2023 | $36.5M | $465.6M | $34.8M |
| Mar 2024 | $30.2M | $868.8M | $115.1M |
| Jun 2024 | $31.9M | $845.6M | $42.7M |
| Sep 2024 | $37.3M | $823.2M | $36.4M |
| Dec 2024 | $45.3M | $792.3M | $28.4M |
| Mar 2025 | $36.5M | $739.5M | $17.1M |
| Jun 2025 | $37.0M | $692.4M | $23.0M |
| Sep 2025 | $50.1M | $648.4M | $36.0M |
| Dec 2025 | $55.8M | $583.0M | $28.9M |
| Mar 2026 | $55.0M | $511.3M | $35.7M |
| Jun 2026 | $67.8M | $782.3M | $47.5M |